Sphera Funds Management Ltd. Jasper Therapeutics, Inc. Transaction History

Sphera Funds Management Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.42 - $0.93 $2.09 Million - $4.63 Million	-4,974,071 Reduced 87.46%	713,063 $563,000
Q3 2023 Nov 14, 2023	BUY	$0.68 - $1.54 $960,925 - $2.18 Million	1,413,126 Added 33.06%	5,687,134 $3.98 Million
Q2 2023 Aug 14, 2023	BUY	$1.19 - $1.79 $273,700 - $411,700	230,000 Added 5.69%	4,274,008 $5.86 Million
Q1 2023 May 15, 2023	BUY	$1.48 - $2.74 $5.99 Million - $11.1 Million	4,044,008 New	4,044,008 $7.32 Million

5.63M

Ticker JSPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,073,300
Market Cap $821M
Description
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a techniqu...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.